glucagon has been researched along with cyproterone acetate in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (cyproterone acetate) | Trials (cyproterone acetate) | Recent Studies (post-2010) (cyproterone acetate) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 1,845 | 339 | 261 |
| Protein | Taxonomy | glucagon (IC50) | cyproterone acetate (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.225 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.225 | |
| Androgen receptor | Homo sapiens (human) | 0.1408 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.339 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.225 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.045 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendlová, B; Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
1 trial(s) available for glucagon and cyproterone acetate
| Article | Year |
|---|---|
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Blood Glucose; Contraceptive Agents; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Polycystic Ovary Syndrome | 2004 |